Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
- PMID: 9360926
- DOI: 10.1126/science.278.5341.1291
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Abstract
In evaluating current combination drug regimens for treatment of human immunodeficiency virus (HIV) disease, it is important to determine the existence of viral reservoirs. After depletion of CD8 cells from the peripheral blood mononuclear cells (PBMCs) of both patients and normal donors, activation of patient CD4 lymphocytes with immobilized antibodies to CD3 and CD28 enabled the isolation of virus from PBMCs of six patients despite the suppression of their plasma HIV RNA to fewer than 50 copies per milliliter for up to 2 years. Partial sequencing of HIV pol revealed no new drug resistance mutations or discernible evolution, providing evidence for viral latency rather than drug failure.
Comment in
-
HIV survives drug onslaught by hiding out in T cells.Science. 1997 Nov 14;278(5341):1227. doi: 10.1126/science.278.5341.1227. Science. 1997. PMID: 9411749 No abstract available.
Similar articles
-
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.J Infect Dis. 1999 Aug;180(2):320-9. doi: 10.1086/314880. J Infect Dis. 1999. PMID: 10395845 Clinical Trial.
-
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.N Engl J Med. 1998 Oct 29;339(18):1261-8. doi: 10.1056/NEJM199810293391801. N Engl J Med. 1998. PMID: 9791141 Clinical Trial.
-
Prevalence and predictive value of intermittent viremia with combination hiv therapy.JAMA. 2001 Jul 11;286(2):171-9. doi: 10.1001/jama.286.2.171. JAMA. 2001. PMID: 11448280
-
Measuring HIV Persistence on Antiretroviral Therapy.Adv Exp Med Biol. 2018;1075:265-284. doi: 10.1007/978-981-13-0484-2_11. Adv Exp Med Biol. 2018. PMID: 30030797 Review.
-
Can HIV infection be eradicated through use of potent antiviral agents?Curr Opin Infect Dis. 2010 Dec;23(6):628-32. doi: 10.1097/QCO.0b013e32833ff1d0. Curr Opin Infect Dis. 2010. PMID: 20847693 Review.
Cited by
-
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.J Clin Invest. 2015 May;125(5):1901-12. doi: 10.1172/JCI80142. Epub 2015 Mar 30. J Clin Invest. 2015. PMID: 25822022 Free PMC article.
-
HIV-1 integration landscape during latent and active infection.Cell. 2015 Jan 29;160(3):420-32. doi: 10.1016/j.cell.2015.01.020. Cell. 2015. PMID: 25635456 Free PMC article.
-
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.J Infect Dis. 2013 Jul;208(1):50-6. doi: 10.1093/infdis/jis630. Epub 2012 Oct 22. J Infect Dis. 2013. PMID: 23089590 Free PMC article.
-
Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.PLoS One. 2012;7(8):e44163. doi: 10.1371/journal.pone.0044163. Epub 2012 Aug 30. PLoS One. 2012. PMID: 22957000 Free PMC article.
-
The immunosuppressive tuberculosis-associated microenvironment inhibits viral replication and promotes HIV-1 latency in CD4+ T cells.iScience. 2024 Jun 20;27(7):110324. doi: 10.1016/j.isci.2024.110324. eCollection 2024 Jul 19. iScience. 2024. PMID: 39055929 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials